Alexis Rideau
Chief Executive Officer at DEINOVE
Profile
Alexis Rideau is currently the Chief Executive Officer at Deinove SA and Morphochem GmbH.
He holds a doctorate degree from the University of Cambridge, a graduate degree from Université Paris Diderot-Paris 7 and Sorbonne Université, and an MBA from ESCP Europe.
Alexis Rideau active positions
| Companies | Position | Start |
|---|---|---|
| DEINOVE | Chief Executive Officer | 2021-02-16 |
Morphochem GmbH
 Morphochem GmbH Miscellaneous Commercial ServicesCommercial Services Part of Deinove SA, Morphochem GmbH is a German company that engages in research and development of natural sciences, engineering, agricultural sciences, and medicine. The company is based in Munich, Germany. The CEOs are Alexis Rideau, Emmanuel Petiot. The private company was founded in 2018. | Chief Executive Officer | 2020-09-28 |
Training of Alexis Rideau
| University of Cambridge | Doctorate Degree |
| Sorbonne Université | Graduate Degree |
| ESCP Europe | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Université Paris Diderot-Paris 7 | Consumer Services |
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Morphochem GmbH
Morphochem GmbH Miscellaneous Commercial ServicesCommercial Services Part of Deinove SA, Morphochem GmbH is a German company that engages in research and development of natural sciences, engineering, agricultural sciences, and medicine. The company is based in Munich, Germany. The CEOs are Alexis Rideau, Emmanuel Petiot. The private company was founded in 2018. | Commercial Services |
- Stock Market
- Insiders
- Alexis Rideau
